ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 618770 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 618770; 2) Community: the network communities that were significantly associated with the response to NSC 618770; 3) Molecule: the relationships between components within communities and NSC 618770; 4) MDR: the compounds that were significantly associated with the NSC 618770.

NSC Compound Enrichment Correlation
NSC 749518 1-[(2Z)-3-amino-3-phenylprop-2-enoyl]-3-phenyl-1H-pyrazol-5-amine 0.000610795106687085 0.29192935
NSC 762009 Copper(II) complex with quin as a ligand 0.000610795106687085 0.52013033
NSC 87500 Solacongestidine 0.000610795106687085 0.37036489
NSC 123463 Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) 0.00061365589440402 0.29484171
NSC 135929 Null 0.00061365589440402 0.52971884
NSC 626878 Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride 0.000613655894404025 0.79311717
NSC 628115 9-N(N'-chloroethyl-N'-methyl-1,2-diaminoethyl) 2 methoxyacridine dihydrochloride 0.000613655894404025 0.59865417
NSC 630602 1-Piperidinecarboxylic acid, 4-oxo-3,5-bis(phenyl- methylene)-, ethyl ester 0.000613655894404025 0.68635249
NSC 643740 Null 0.000613655894404025 0.36447725
NSC 674196 Null 0.000613655894404025 0.67894933
Total:163  Current:12    [First] [Prev] [Next] [Last]